(SECT-B) Sectra (publ) - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0018245953
SECT-B: Medical Imaging, Secure Communications, Orthopedic Planning
Sectra AB (publ) is a Swedish company specializing in medical IT and cybersecurity solutions, operating primarily in Sweden, the UK, the Netherlands, and other European markets. The company is structured into three core business segments: Imaging IT Solutions, Secure Communications, and Business Innovation. The Imaging IT Solutions segment focuses on developing and delivering medical IT systems for managing, archiving, and presenting medical images and patient information. It also provides operational follow-up tools, radiation dose monitoring solutions, and consulting services for integration, system design, and data migration. Additionally, this segment offers maintenance and support services to ensure system reliability and performance.
The Secure Communications segment is centered on secure voice and data communication solutions, catering to organizations requiring high-level security. This includes project-based development, security and threat analyses, and system monitoring services, particularly for critical infrastructure such as power grids and transportation systems. The Business Innovation segment, on the other hand, focuses on niche healthcare IT solutions, including orthopedic surgery planning systems and products for medical education and research. Sectras solutions are primarily targeted at hospitals and private clinic chains, where precise and secure data management is critical.
Founded in 1957 and headquartered in Linköping, Sweden, Sectra AB (publ) has established itself as a key player in both medical IT and cybersecurity. Its deep expertise in these fields has enabled the company to deliver tailored solutions that meet the stringent requirements of healthcare and critical infrastructure sectors. Sectras commitment to innovation and customer-centric approach has positioned it as a trusted partner for organizations seeking reliable and secure IT systems.
Additional Sources for SECT-B Stock
SECT-B Stock Overview
Market Cap in USD | 5,475m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Pharmaceuticals |
IPO / Inception |
SECT-B Stock Ratings
Growth Rating | 71.8 |
Fundamental | 68.4 |
Dividend Rating | 44.8 |
Rel. Strength | 34.1 |
Analysts | - |
Fair Price Momentum | 333.21 SEK |
Fair Price DCF | 85.91 SEK |
SECT-B Dividends
Dividend Yield 12m | 0.40% |
Yield on Cost 5y | 1.43% |
Annual Growth 5y | 4.10% |
Payout Consistency | 82.2% |
SECT-B Growth Ratios
Growth Correlation 3m | 26.1% |
Growth Correlation 12m | 40.2% |
Growth Correlation 5y | 80.3% |
CAGR 5y | 30.93% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 1.69 |
Alpha | 26.88 |
Beta | 0.416 |
Volatility | 37.01% |
Current Volume | 101.8k |
Average Volume 20d | 145.7k |
As of May 01, 2025, the stock is trading at SEK 296.60 with a total of 101,785 shares traded.
Over the past week, the price has changed by +7.54%, over one month by +23.92%, over three months by +16.77% and over the past year by +36.35%.
Yes, based on ValueRay Fundamental Analyses, Sectra (publ) (ST:SECT-B) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 68.42 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SECT-B as of May 2025 is 333.21. This means that SECT-B is currently undervalued and has a potential upside of +12.34% (Margin of Safety).
Sectra (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, SECT-B Sectra (publ) will be worth about 365.3 in May 2026. The stock is currently trading at 296.60. This means that the stock has a potential upside of +23.16%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 250 | -15.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 365.3 | 23.2% |